Allergen immunotherapy in children and adolescents with respiratory diseases
To date, the only disease-modifying treatment strategy for allergic rhinitis and asthma is allergen immunotherapy (AIT). There is evidence that AIT improves allergic rhinitis and asthma, such as reducing symptom severity and medication use and improving of quality of life, with a long-lasting effect after the end of the course. The recent clinical trials evidenced AIT effectiveness and safety in allergic asthma. Consequently, the current version of the GINA (Global Initiative for Asthma) guidelines recommend AIT as an add-on therapy for asthma. There is also evidence that AIT may exert preventive activity on the possible progression from allergic rhinitis to asthma in children and the onset of new sensitizations.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:91 |
|---|---|
| Enthalten in: |
Acta bio-medica : Atenei Parmensis - 91(2020), 11-S vom: 15. Sept., Seite e2020006 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tosca, Maria Angela [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 25.06.2021 Date Revised 25.06.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.23750/abm.v91i11-S.10309 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315751673 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315751673 | ||
| 003 | DE-627 | ||
| 005 | 20231225155607.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.23750/abm.v91i11-S.10309 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1052.xml |
| 035 | |a (DE-627)NLM315751673 | ||
| 035 | |a (NLM)33004776 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tosca, Maria Angela |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Allergen immunotherapy in children and adolescents with respiratory diseases |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.06.2021 | ||
| 500 | |a Date Revised 25.06.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a To date, the only disease-modifying treatment strategy for allergic rhinitis and asthma is allergen immunotherapy (AIT). There is evidence that AIT improves allergic rhinitis and asthma, such as reducing symptom severity and medication use and improving of quality of life, with a long-lasting effect after the end of the course. The recent clinical trials evidenced AIT effectiveness and safety in allergic asthma. Consequently, the current version of the GINA (Global Initiative for Asthma) guidelines recommend AIT as an add-on therapy for asthma. There is also evidence that AIT may exert preventive activity on the possible progression from allergic rhinitis to asthma in children and the onset of new sensitizations | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Licari, Amelia |e verfasserin |4 aut | |
| 700 | 1 | |a Olcese, Roberta |e verfasserin |4 aut | |
| 700 | 1 | |a Castagnoli, Riccardo |e verfasserin |4 aut | |
| 700 | 1 | |a Marseglia, Alessia |e verfasserin |4 aut | |
| 700 | 1 | |a Marseglia, Gian Luigi |e verfasserin |4 aut | |
| 700 | 1 | |a Miraglia Del Giudice, Michele |e verfasserin |4 aut | |
| 700 | 1 | |a Martelli, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Calvani, Mauro |e verfasserin |4 aut | |
| 700 | 1 | |a Caffarelli, Carlo |e verfasserin |4 aut | |
| 700 | 1 | |a Duse, Marzia |e verfasserin |4 aut | |
| 700 | 1 | |a Cravidi, Claudio |e verfasserin |4 aut | |
| 700 | 1 | |a Cardinale, Fabio |e verfasserin |4 aut | |
| 700 | 1 | |a Ciprandi, Giorgio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta bio-medica : Atenei Parmensis |d 2002 |g 91(2020), 11-S vom: 15. Sept., Seite e2020006 |w (DE-627)NLM12090733X |x 2531-6745 |7 nnns |
| 773 | 1 | 8 | |g volume:91 |g year:2020 |g number:11-S |g day:15 |g month:09 |g pages:e2020006 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.23750/abm.v91i11-S.10309 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 91 |j 2020 |e 11-S |b 15 |c 09 |h e2020006 | ||